Validation Study of In Vitro Cytotoxicity Test Methods
ICCVAM has issued recommendations on in vitro cytotoxicity test methods in the ICCVAM Test Method Evaluation Report: In Vitro Cytotoxicity Test Methods for Estimating Starting Doses for Acute Oral Systemic Toxicity Tests (NIH Publication No. 07-4519).
ICCVAM recommends:
- In vitro basal cytotoxicity test methods should be considered before using animals in acute oral systemic toxicity testing.
- Data from these test methods should be used in a weight-of-evidence approach in determining starting doses for in vivo studies. Proper use of these methods can reduce the number of animals required for each toxicity test.
ICCVAM determined that the evaluated in vitro test methods are not accurate enough to replace animals for regulatory hazard classification purposes.
Letters communicating ICCVAM recommendations to federal agencies and responses from the agencies can be found below.
Background
NICEATM and the European Centre for the Validation of Alternative Methods (ECVAM, now known as EURL ECVAM) conducted a validation study on the BALB/c 3T3 neutral red uptake and the normal human keratinocyte (NHK) neutral red uptake assays. The study generated in vitro cytotoxicity data to predict rodent in vivo LD50 values and starting doses for acute oral systemic toxicity test methods. These in vitro tests used rodent (mouse fibroblast [3T3]) and human (NHK) cells.
Study Objectives
- Further standardize and improve the in vitro basal cytotoxicity protocols to maximize test reliability (intra- and interlaboratory reproducibility).
- Assess the accuracy of the standardized in vitro cytotoxicity test methods for estimating rodent oral LD50 values across the five GHS acute oral systemic toxicity categories, as well as unclassified toxicities.
- Estimate the reduction and refinement in animal use achievable from using the in vitro basal cytotoxicity test methods to identify starting doses for in vivo acute oral systemic toxicity tests.
- Develop databases containing high-quality data from in vivo acute oral lethality and in vitro basal cytotoxicity tests. These databases would be used to support the investigation of other test methods necessary to improve predictions of in vivo acute oral lethality.
Related Documents
- Background Review Document: In Vitro Cytotoxicity Test Methods for Estimating Acute Oral Systemic Toxicity (NIH Publication No. 07-4518)
- OECD Series on Testing and Assessment No. 129: Guidance Document on Using Cytotoxicity Tests to Estimate Starting Doses for Acute Oral Systemic Toxicity Tests
- ICCVAM-Recommended Protocols
- BALB/c 3T3 Neutral Red Uptake Assay
- Normal Human Keratinocyte (NHK) Neutral Red Uptake Assay
- Test Chemical Solubility Protocol used in the validation study
- Data Templates and Other Validation Study Information: contact NICEATM
Conclusions and Regulatory Acceptance
An independent scientific peer review panel was convened in May 2006 to evaluate the study, and concluded that these in vitro cytotoxicity test methods should be considered for use in a weight-of-evidence approach to determine starting doses for acute oral systemic toxicity test methods, reducing overall animal use requirements. However, the panel concluded that these in vitro cytotoxicity test methods could not be used to determine the hazard classification of chemicals. ICCVAM agreed with both conclusions.
The validation study was used as the basis for the European Union's ACuteTox project. The aim was to develop a battery of in vitro tests sufficiently robust and powerful to replace in vivo tests used to determine the acute toxicity of chemicals and products.
Use of the in vitro starting dose procedure was accepted internationally in 2010 via the OECD Guidance Document on Using Cytotoxicity Tests to Estimate Starting Doses for Acute Oral Systemic Toxicity Tests ("Guidance Document 129").
Transmittal Letters and Agency Responses
- National Institute of Environmental Health Sciences (NIEHS)
- Agency for Toxic Substances and Disease Registry (ATSDR)
- Consumer Product Safety Commission (CPSC)
- Environmental Protection Agency (EPA)
- Food and Drug Administration (FDA)
- National Cancer Institute (NCI)
- National Institutes of Health (NIH)
- National Institute for Occupational Safety and Health (NIOSH)
- National Library of Medicine (NLM)
- Occupational Safety and Health Administration (OSHA)
- U.S. Department of Agriculture
- U.S. Department of Defense
- U.S. Department of Energy
- U.S. Department of the Interior
- U.S. Department of Transportation
Evaluation of In Vitro Cytotoxicity Test Methods
The validation study was a follow-up activity from the International Workshop on In Vitro Methods for Assessing Acute Systemic Toxicity held in October 2000. Following this workshop, ICCVAM recommended further evaluation of the use of in vitro cytotoxicity data to estimate the starting doses for rodent acute oral systemic toxicity studies, which was accomplished in the validation study. The 2000 workshop had two work products:
- Report of the International Workshop on In Vitro Methods for Assessing Acute Systemic Toxicity (NIH Publication No. 01-4499)
- Guidance Document on Using In Vitro Data to Estimate In Vivo Starting Doses for Acute Toxicity (NIH Publication No. 01-4500)
Transmittal of ICCVAM Recommendations and Agency Responses
Agency Responses
- National Institute of Environmental Health Sciences (NIEHS)
Letter from Dr. Olden to the NIEHS Record (September 9, 2003) - Agency for Toxic Substances and Disease Registry (ATSDR)
Response from Henry Falk, Assistant Administrator (August 25, 2003) - Consumer Products Safety Commission (CPSC)
Response from Todd Stevenson, Office of the Secretary (September 9, 2003) - Environmental Protection Agency (EPA)
Response from Joseph Merenda, Director, Office of Science Coordination and Policy (December 2, 2003) - Food and Drug Administration (FDA)
Response from Mark McClellan, Commissioner of Food and Drugs (September 9, 2003) - National Cancer Institute (NCI)
Response from Andrew von Eschenbach, Director (August 25, 2003) - National Institutes of Health (NIH)
Response from Elias Zerhouni, Director (September 5, 2003) - National Institute for Occupational Safety and Health (NIOSH)
Response from John Howard, Director (September 30, 2003) - National Library of Medicine (NLM)
Response from Donald Lindberg, Director (August 8, 2003) - Occupational Safety and Health Administration (OSHA)
Response from John Henshaw, Office of the Assistant Secretary - U.S. Department of Agriculture
Response from Bobby Acord, Administrator, Animal and Plant Health Inspection Service (September 22, 2003) - U.S. Department of Defense
Response from Charles Holland, Deputy Undersecretary of Defense for Science and Technology (September 30, 2003) - U.S. Department of Energy
Response from Marvin Frazier, Director, Life Sciences Division (September 24, 2003) - U.S. Department of the Interior
Response from Charles Groat, Director, U.S. Geological Survey (August 27, 2003) - U.S. Department of Transportation
Response from Samuel Bonasso, Acting Director, Research and Special Programs Administration (May 7, 2003)